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The Addition of Arachidin 1 or Arachidin 3 to Human Rotavirus-infected Cells 
Inhibits Viral Replication and Alters the Apoptotic Cell Death Pathway	
Rotavirus  (RV)  infections  are  a  leading  cause  of  severe 
gastroenteritis  in  infants  and children under  the age of  five.  There 
are two vaccines available in the United States and one in India that 
can  be  administered  early  in  childhood,  however  they  only  protect 
against  specific  strains1.  From our  previous  work,  both  arachidin-1 
(A1)  and  arachidin-3  (A3)  from  peanut  (Arachis  hypogaea)  hairy 
root  cultures  significantly  inhibit  simian  RV  replication2,3,4.  The 
purpose  of  this  study  was  to  determine  if  a  human  intestinal  cell 
line,  HT29.f8,  infected  with  a  human  RV,  Wa,  was  affected  by  A1 
and A3. Cell viability assays were utilized to determine if A1 and A3 
affect  the  HT29.f8  cells  with/without  RV  infections.   At  eighteen 
hours  post  infection  (hpi),  supernatants  from  the  RV-infected 
HT29.f8  cells  with/without  the  arachidins  were  used  in  plaque 
forming  assays  to  quantify  and  compare  the  amount  of  infectious 
RV  particles  that  are  produced  during  an  infection.  Transmission 
electron microscopy (TEM) was used to visualize cell ultrastructure 
and  individual  RV  particles.  Additionally,  tunable  resistive  pulse 
sensing  technology  (TRPS)  using  the  qNano  system  by  IZON  was 
employed to quantify and measure virus particle  sizes,  and display 
the  size  distribution  of  RV  particles.   Likewise,  quantitative  real 
time  polymerase  chain  reactions  (qRT-PCR)  were  performed  to 
determine  if  A1  and  A3  regulated  cell  death  pathways  in  the 
HT29.f8  cell  line.  This  data  will  guide  our  future  studies  to 
determine the antiviral mechanism(s) of action of A1 and A3.
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Plaque Forming Unit Assays (PFU/ml) 
v  Incubate log-fold dilutions 
of infected cell 
supernatants with/without 
Arachidins on MA104 cells   
v  Add medium and Agarose 
v  Stain cells with neutral red 
and count plaques 
Transmission Electron Microscopy (TEM) 
v  Cells were fixed in a resin 
mold 
v  Ultra-microtome 
v  Load to grid 
v  Stain 
v  Uranyl acetate 
v  Lead citrate 
3.  RV (Wa) + Worthington Trypsin (1µg/ml)        
 + 20µM A1/3 
2.  RV (Wa) + Worthington Trypsin (1µg/ml)  
4.  Uninfected + 20µM A1/3 
1.  Uninfected + no treatment  1.  
2.  
3.  
4.  
Conclusion	
RV plaques in 
HT29.f8 cells 
From  the  data  collected,  the  viability  of  the  cells 
was  not  impacted  with  the  introduction  of  A1  or 
A3,  therefore  the  arachidins  do  not  adversely 
affect  the  cells.   However,  the  amount  of 
infectious  virus  particles  produced  when  treated 
with  A1  and  A3  was  decreased  by  approximately 
one  hundred  fold  and  were  both  statistically 
significant  (p=2.4E-5).   Also,  TRPS  analysis 
showed  a  size  pattern  of  distribution  of  particles 
that  was  consistent  with  the  size  range  of  virus 
particles  measured  by  TEM  of  the  more  mature 
noneveloped  RV  (neRV  67-73.5nm)  and  more 
immature  enveloped  RV  (eRV  111-117nm).  In 
addition,  TRPS  analysis  of  RV  only  supernatants 
demonstrated a size population that  is  consistent 
with infectious RV, but with a few larger immature 
RV  particles.   On  the  other  hand,  the  arachidin 
treated  cell  supernatants  show  a  population  of 
more  immature  RV  sizes.  This  suggests  that  the 
arachidins  do  impact  RV  maturation.   The  TEM 
images depicted changes of the ultrastructures of 
RV-infected HT29.f8 cells, and indicates apoptosis 
while  RV-infected  cells  with  the  addition  of  A1  or 
A3  showed  signs  of  the  autophagy  pathway.  The 
nucleus  to  cytoplasm  ratios  of  TEM  micrographs 
(n=12  per  treatment)  of  the  cells  from  each  of 
the  treatment  groups  demonstrated  that  the 
increase  in  the  nucleus  observed  with  RV  alone 
was decreased with the addition of the arachidins 
to  a  similar  size  of  the  untreated  or  arachidin 
alone  cells.  qRT-PCR  analysis  of  gene  transcripts, 
that are important in regulations of the apoptosis 
and  autophagy  pathways,  validated  the  TEM 
observation.  The  up  regulation  of  the  apoptosis 
transcripts were down regulated with the addition 
of the arachidins.  Whereas only beclin-1 and bcl-2 
where  regulated  like  the  apoptosis  transcripts.  
This  pattern  of  regulation  implies  a  cross  talk 
between  the  two  pathways.  Our  data  suggest  a 
mechanism  of  action  of  two  natural  small 
molecules  showing  anti-RV  activity  that  implies 
potential therapeutic applications.
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